Dana Small Cap Equity
As of: August 29, 2018
Dana Epiphany ESG Small Cap Equity Fund
Fund Information
as of 10/31/20
| SYMBOL | DSCIX |
| INCEPTION DATE | 11/2/15 |
| BENCHMARK | Russell 2000 Index |
| TOTAL FUND AUM | $9.86 MM |
| TOTAL FIRM AUM | $6.6 BN |
| MIN. INVESTMENT | $5,000 |
| NET EXPENSE RATIO | 0.95% |
| GROSS EXPENSE RATIO | 1.88% |
| NUMBER OF HOLDINGS | 60 – 65 |
| TARGET CASH POSITION | 0 – 1% |
| INDIVIDUAL SECURITY LIMIT | < 4% |
| SECTOR LIMITS | SECTOR NEUTRAL |
Data source: Morningstar Direct; The Adviser has contractually agreed to waive its management fee and/or reimburse certain operating expenses through 2/28/2021, so that Total Annual Operating Expenses does not exceed 0.95% for the Fund. Time period for statistical calculations is from fund inception to 10/31/20.
Top Holdings
as of 10/31/20, subject to change. Current and future portfolio holdings are subject to risk
| BLUEPRINT MEDICINES CORP. | 2.44% |
| OMNICELL, INC. | 2.22% |
| DECKERS OUTDOOR CORPORATION | 2.16% |
| TOPBUILD CORP. | 2.15% |
| BOOT BARN HOLDINGS, INC. | 2.07% |
| EMERGENT BIOSOLUTIONS, INC. | 2.04% |
| ENSIGN GROUP, INC. | 2.02% |
| COHU, INC. | 2.01% |
| HORIZON THERAPEUTICS PLC | 1.99% |
| E.L.F. BEAUTY, INC. | 1.90% |